Plain-English translation of NCT05698732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is tracking the safety and effectiveness of the Coroflex® ISAR NEO stent, a small wire mesh tube used to keep narrowed heart arteries open. The study will follow about 3,000 patients in multiple countries who receive this stent as part of their regular heart treatment. Researchers want to make sure this medication performs safely in real-world patients, not just in controlled research settings.
Heart stents are a standard treatment for blocked arteries, but manufacturers need to continuously monitor how new stent designs perform in actual patient populations. This study helps confirm that the treatment remains safe and effective when used by doctors in hospitals and clinics around the world.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive the heart stent during a standard procedure at a hospital or clinic. After that, the research team will follow up with you at regular intervals over time to check how well the stent is working and monitor your health. You'll likely have office visits, heart imaging tests, and may be asked questions about any symptoms or medications you're taking.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
France